60 related articles for article (PubMed ID: 18049093)
1. Reduced thalamic 18F-flurodeoxyglucose retention in adults with neurofibromatosis type 1.
Buchert R; von Borczyskowski D; Wilke F; Gronowsky M; Friedrich RE; Brenner W; Mester J; Clausen M; Mautner VF
Nucl Med Commun; 2008 Jan; 29(1):17-26. PubMed ID: 18049093
[TBL] [Abstract][Full Text] [Related]
2. Cerebral glucose metabolism in adults with neurofibromatosis type 1.
Apostolova I; Derlin T; Salamon J; Amthauer H; Granström S; Brenner W; Mautner VF; Buchert R
Brain Res; 2015 Nov; 1625():97-101. PubMed ID: 26335059
[TBL] [Abstract][Full Text] [Related]
3. Asymmetry of thalamic hypometabolism on FDG-PET/CT in neurofibromatosis type 1: Association with peripheral tumor burden.
Özden C; Mautner VF; Farschtschi S; Molwitz I; Ristow I; Bannas P; Well L; Klutmann S; Adam G; Apostolova I; Buchert R
J Neuroimaging; 2024; 34(1):138-144. PubMed ID: 37942683
[TBL] [Abstract][Full Text] [Related]
4. Value of PET in the assessment of patients with neurofibromatosis type 1.
Bredella MA; Torriani M; Hornicek F; Ouellette HA; Plamer WE; Williams Z; Fischman AJ; Plotkin SR
AJR Am J Roentgenol; 2007 Oct; 189(4):928-35. PubMed ID: 17885067
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients.
Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P
PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography in children with neurofibromatosis-1.
Kaplan AM; Chen K; Lawson MA; Wodrich DL; Bonstelle CT; Reiman EM
J Child Neurol; 1997 Nov; 12(8):499-506. PubMed ID: 9430315
[TBL] [Abstract][Full Text] [Related]
7. [Thalamic metabolism and neurological outcome after traumatic brain injury. A voxel-based morphometric FDG-PET study].
Lull N; Noé E; Lull JJ; García-Panach J; García-Martí G; Chirivella J; Ferri J; Sopena R; de La Cueva L; Robles M
Neurologia; 2010 Apr; 25(3):174-80. PubMed ID: 20492864
[TBL] [Abstract][Full Text] [Related]
8. Thalamic hypofunction in alcohol hallucinosis: FDG PET findings.
Soyka M; Koch W; Tatsch K
Psychiatry Res; 2005 Aug; 139(3):259-62. PubMed ID: 16043330
[TBL] [Abstract][Full Text] [Related]
9. Age-associated changes of cerebral glucose metabolic activity in both male and female deaf children: parametric analysis using objective volume of interest and voxel-based mapping.
Kang E; Lee DS; Kang H; Lee JS; Oh SH; Lee MC; Kim CS
Neuroimage; 2004 Aug; 22(4):1543-53. PubMed ID: 15275911
[TBL] [Abstract][Full Text] [Related]
10. A voxel-based analysis of FDG-PET in traumatic brain injury: regional metabolism and relationship between the thalamus and cortical areas.
García-Panach J; Lull N; Lull JJ; Ferri J; Martínez C; Sopena P; Robles M; Chirivella J; Noé E
J Neurotrauma; 2011 Sep; 28(9):1707-17. PubMed ID: 21770759
[TBL] [Abstract][Full Text] [Related]
11. Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management.
Basu S; Houseni M; Alavi A
Nucl Med Commun; 2008 Apr; 29(4):367-73. PubMed ID: 18317302
[TBL] [Abstract][Full Text] [Related]
12. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Salamon J; Mautner VF; Adam G; Derlin T
Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
[TBL] [Abstract][Full Text] [Related]
13. Remote effects in the ipsilateral thalamus and/or contralateral cerebellar hemisphere using FDG PET in patients with brain tumors.
Iwasa H; Murata Y; Nishimori M; Miyatake K; Tadokoro M; Kohsaki S; Nogami M; Ueba Y; Ueba T; Yamagami T
Jpn J Radiol; 2018 Apr; 36(4):303-311. PubMed ID: 29372376
[TBL] [Abstract][Full Text] [Related]
14. Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.
Visser EP; Philippens ME; Kienhorst L; Kaanders JH; Corstens FH; de Geus-Oei LF; Oyen WJ
J Nucl Med; 2008 Jun; 49(6):892-8. PubMed ID: 18483085
[TBL] [Abstract][Full Text] [Related]
15. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
Juh R; Kim J; Moon D; Choe B; Suh T
Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
[TBL] [Abstract][Full Text] [Related]
16. Increased 18F-FDG uptake in degenerative disease of the spine: Characterization with 18F-FDG PET/CT.
Rosen RS; Fayad L; Wahl RL
J Nucl Med; 2006 Aug; 47(8):1274-80. PubMed ID: 16883005
[TBL] [Abstract][Full Text] [Related]
17. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
Cohade C; Osman M; Pannu HK; Wahl RL
J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
[TBL] [Abstract][Full Text] [Related]
18. Thalamic hypometabolism in a patient undergoing vagal nerve stimulation seen on F-18 FDG PET imaging.
Petrucci M; Hoh C; Alksne JF
Clin Nucl Med; 2003 Sep; 28(9):784-5. PubMed ID: 12973011
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
[TBL] [Abstract][Full Text] [Related]
20. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
